The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …

The global burden of bacterial resistance remains one of the most serious public health
concerns. Infections caused by multidrug-resistant (MDR) bacteria in critically ill patients …

Introduction The increasing prevalence of infections with multidrug-resistant (MDR),
extensively-drug resistant (XDR) or difficult-to-treat drug resistant (DTR) Gram-negative …

This study aimed to investigate the geographical trends of minimum inhibitory
concentrations (MICs) for tigecycline and colistin in Acinetobacter baumannii, Escherichia …

Colistin, the last resort for multidrug and extensively drug-resistant bacterial infection
treatment, was reintroduced after being avoided in clinical settings from the 1970s to the …

The rise in antimicrobial resistant bacteria is limiting the number of effective treatments for
bacterial infections. Escherichia coli and Pseudomonas aeruginosa are two of the …

This study evaluated the in-vitro activity of multiple classes of antibiotics, including novel β-
lactam combination agents, tigecycline and colistin, against carbapenem-resistant (CRAB) …

Modern drug delivery to tackle infectious disease has drawn close to personalizing medicine
for specific patient populations. Challenges include antibiotic-resistant infections, healthcare …

Background Acinetobacter nosocomialis (A. nosocomialis) is a glucose non-fermentative,
gram-negative bacillus that belongs to the Acinetobacter calcoaceticus-baumannii complex …

Immunocompromised patients are particularly vulnerable to infections caused by S.
maltophilia and E. anophelis, but the optimal treatment strategy remains inconclusive …